about
Antibiotic lock therapy: review of technique and logistical challengesKnowledge and attitudes of doctor of pharmacy students regarding the appropriate use of antimicrobialsStaphylococcus aureus infection of the optic nervePharmacokinetics of ceftaroline in normal body weight and obese (classes I, II, and III) healthy adult subjectsCumulative effect of an antimicrobial stewardship and rapid diagnostic testing bundle on early streamlining of antimicrobial therapy in gram-negative bloodstream infections.Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections.Efficacy of inhaled ciprofloxacin in the management of non-cystic fibrosis bronchiectasis.Adverse reactions associated with systemic polymyxin therapy.Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections.Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections.Application of Fluoroquinolone Resistance Score in Management of Complicated Urinary Tract InfectionsClinical Risk Score for Prediction of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates.Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis.Differential effect of prior β-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa.Association between chronic hemodialysis and bloodstream infections caused by chromosomally mediated AmpC-producing Enterobacteriaceae.Development of Institutional Guidelines for Management of Gram-Negative Bloodstream Infections: Incorporating Local Evidence.Duration of Antimicrobial Therapy for Enterobacteriaceae Bacteremia: Using Convenient End Points for Convenient Conclusions.Combination versus monotherapy for gram-negative bloodstream infections: matching by predicted prognosis.Reply to comments: duration of antimicrobial therapy for Gram-negative bacteremia secondary to urinary source of infection.Impact of Penicillin Allergy on Empirical Carbapenem Use in Gram-Negative Bloodstream Infections: An Antimicrobial Stewardship Opportunity.Antimicrobial Stewardship Training for Infectious Diseases Fellows: Program Directors Identify a Curriculum Need.Preventing the Post-Antibiotic Era by Training Future Pharmacists as Antimicrobial StewardsRole of Early De-escalation of Antimicrobial Therapy on Risk of Clostridioides difficile Infection following Enterobacteriaceae Bloodstream InfectionsIgnoring the Elephant: Does the Infectious Diseases Society of America Support Sepsis-3 or Pre-sepsis Criteria?Bloodstream Infection due to Piperacillin/Tazobactam Non-Susceptible, Cephalosporin-Susceptible : A Missed Opportunity for De-Escalation of TherapyUtility of Combination Antimicrobial Therapy in Adults with Bloodstream Infections due to Enterobacteriaceae and Non-Fermenting Gram-Negative Bacilli Based on In Vitro Analysis at Two Community HospitalsCommentary on "incidence and predictors of vancomycin-associated nephrotoxicity"Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control studyPenicillin Allergy Assessment and Skin Testing in the Outpatient SettingImpact of Reappraisal of Fluoroquinolone Minimum Inhibitory Concentration Susceptibility Breakpoints in Gram-Negative Bloodstream IsolatesSeasonal variation in antimicrobial resistance rates of community-acquired Escherichia coli bloodstream isolatesEvaluation of early clinical failure criteria for gram-negative bloodstream infectionsDirect Measurement of Performance: A New Era in Antimicrobial StewardshipSyndrome-specific versus prospective audit and feedback interventions for reducing use of broad-spectrum antimicrobial agentsPenicillin Allergy Skin Testing in the Inpatient SettingPharmacist-Driven Culture and Sexually Transmitted Infection Testing Follow-Up Program in the Emergency Department
P50
Q28082777-74B8CFF7-05FA-4450-BB48-6DAFC2A259C6Q28651700-13F08CE5-0745-45D6-979A-0AC5E4B98B0AQ35684455-48712767-0FEC-4202-A240-2A64FD7CC190Q35746176-EE4CED43-FAD3-4583-B009-002A161AEFA6Q36409825-D3D3AA9E-A8EC-464E-9517-FDA537177F20Q36729974-604158CC-AF93-4F5D-AA0A-5506E3B81F1EQ38108277-DB57D142-D64F-4CDF-9E97-E4F8335E373DQ38255373-12C9A6EF-9DDE-49D1-B8C8-40356DEE39E4Q39426648-FC2FF3A1-6169-4DB0-A296-B38EB875EDAAQ40223658-7642210C-CF76-4194-8101-2DE18FD1B387Q40334475-BD12C266-AEDA-4751-BBDE-32D309262113Q40405283-618B2637-06DD-43B7-9D19-564587261392Q40406041-BA7C5358-3A8F-4F12-8A52-D2DBCC329AC3Q40465122-6443FE47-9DE2-44AF-87F2-1F67F7CD903BQ40585190-3C4D68B2-042E-482F-BA65-E6B94466FE1DQ49587319-22BB672C-EA92-4A75-BCA0-76BA62236718Q49819943-35831BB9-98F8-4E02-AA26-9D1E83EEC613Q50053518-DA79FD92-99FE-4729-ADD0-8AE695A137FAQ50125675-CDB200C6-CD76-4D38-8161-5844307E368BQ50145400-1B0F63AE-590B-4ACF-B921-0038E60D7368Q54233220-8240B48E-D837-422C-BC40-EC67C6806856Q57171376-4647EB3B-B16D-4D03-A478-2515D7CF63ADQ57470680-6A316AE7-6A92-418A-8AA5-E2B233367648Q57864604-323343D1-3FC2-46F1-87DE-A28B87064675Q60922047-072A8048-62E3-45D1-AEAE-034613B6174FQ64229824-0C72E61D-BA6C-46BC-8820-DF09CFD88E28Q88110972-2F1E2E02-9F1E-4B7F-8A28-1CDE7708CBCAQ88646592-9FC70A8F-89C1-421B-BFAF-26AEF689CA2BQ90226559-B4FC8A82-8836-4714-B2A6-F717F2EC25D5Q92123070-F74FAA21-4CA4-45F4-B80A-3C932F8F150FQ92457863-8BA9BD14-C391-45FE-984E-99A45F791B72Q92489891-7D068B4A-65AA-48D8-95E0-3BAC8384A598Q92874486-01CF263B-B979-4111-8808-71FFF806A4B2Q92914048-C3578C6F-9117-4752-8B04-C8E7313B9E84Q92959418-B8E9F773-C253-426C-865E-39D4B0BC3600Q93262751-508D2170-8029-4839-830B-8AC3D20AFC79
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Julie Ann Justo
@en
Julie Ann Justo
@nl
type
label
Julie Ann Justo
@en
Julie Ann Justo
@nl
prefLabel
Julie Ann Justo
@en
Julie Ann Justo
@nl
P31
P496
0000-0002-4161-9577